Skip to main content

Table 2 Demographic data and OA history

From: Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial

Patients

 

N

22 (M: 7-F: 15)

Age

64.3 ± 8.4 years

Pain history

48.5 ± 48.2 months

Knee pain

 

- Left

4.6%

- Right

31.8%

- Both

63.6%

Radiographic knee OA severity score (K&L)

 

- I

13.6%

- II

50.0%

- III

31.8%

- IV

4.6%

Night pain

 

  -Yes

59.1%

  -No

40.9%

Effusion

 

  -Yes

31.8%

  -No

68.2%